期刊文献+

高血压内皮功能失调机制的研究进展 被引量:4

下载PDF
导出
摘要 内皮功能失调是高血压的特征性异常变化之一。本文就内皮源性舒张因子、内皮源性收缩因子在高血压内皮功能失调机制和高血压病理生理发展中的作用作一综述。
出处 《国外医学(内科学分册)》 2001年第7期281-283,293,共3页 Foreign Medical Sciences(Section of Internal Medicine)
  • 相关文献

参考文献18

  • 1[1]Haynes WG, Webb DJ. [J]. J Hypertens, 1998, 16(8): 1081-1098.
  • 2[2]Hocher B,Thone-Reinecke C,Rohmeiss P, et al. [J].J Clin Invest, 1997,99:1380-1389.
  • 3[3]Radaelli A, Mircoli L, Mori I. [J]. Hypertention,1998,32: 735-739.
  • 4[4]Shiro K, Kensuke E, Chu K, et al. [J]. J Hypertens,2000,18:1795-1800.
  • 5[5]Kerr S, Brosnan MJ, McIntyre M, et al. [ J]. Hypertention, 1999,33:1353-1358.
  • 6[6]Laursen JB,Rajagopalan S, Falis Z,et al. [J]. Circulation, 1997,95: 588-593.
  • 7[7]Barton M,Haudenschild CC,d'Uscio LV,et al. [J].Nephrology, 1997,3: S32.
  • 8[8]Hraij LH. [J]. Hypertention,1997,29:235-241.
  • 9[9]Cardillo C,kilcoyne CM,Quyyumi AA,et al. [J]. Circulation, 1998,97: 851-856.
  • 10[10]Taddei S,Virdis A,Ghiadoni L, et al. [J]. Hypertention, 1997,29(Pt 2) :274-279.

同被引文献50

  • 1齐晓勇,孟存良,谷剑,李树仁,张建清,王天红,党懿,李英肖.同型半胱氨酸与不稳定型心绞痛患者介入治疗早期并发症的关系[J].临床心血管病杂志,2006,22(2):73-76. 被引量:3
  • 2TEKIN A, TEKIN G, GUZELSOY D, et al. Effects of atorvastatin (10 mg) on hemostatic and inflamma- tory parameters in hyperlipidemic patients with anglographically proven coronary artery disease[J]. Am J Cardiol, 2004, 94:206-209.
  • 3CECONI C, FOX K M, REMME W J, et al. ACE inhibition with perindopril and endothelial function[J]. Cardiovasc Res, 2007, 73:237-246.
  • 4BOOS C J, BALAKRISHNAN B, BLANN A D, et al. The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis[J]. J Thromb Haemost, 2008, 6:1841 -1850.
  • 5BOOS C J, BAI.AKRISHNAN B, JESSANI S, et al. Effects of pereutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction[J]. Chest, 2007, 132:1920-1926.
  • 6GOROG D A, DOUGLAS H, AHMED N, et al. Coronary angioplasty enhances platelet reactivity through yon Willebrand factor release[J]. Heart, 2003, 89:329-330.
  • 7VARGOVA K, TOTH ZSAMBOKI E, BERES B J, et al. Circulating endothelial cell count, plasma vWF and soluble ICAM-1 levels following primary or elective percutaneous coronary intervention[J]. Atherosclerosis, 2008, 198: 366-372.
  • 8RUGGERI Z M, ORJE J N, HABERMANN R, et al. Activation-independent platelet adhesion and aggregation under elevated shear stress[J].Blood, 2006, 108: 1903-1910.
  • 9CHUNG N A, LYDAKIS C, BELGORE F, et al. Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease[J]. Heart, 2003, 89:1411-1415.
  • 10VARGOVA K, TOTH ZSAMBOKI E, BERES B J, et al. Circulating endothelial cell count, plasma vWF and soluble ICAM-1 levels following primary or elective percutaneous coronary intervention[J]. Atherosclerosis, 2008, 198: 366-372.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部